The influence of opinion leaders

Australian Prescriber

Volumn 35, Issue 3, 2012, Pages 74-75

  Flicker, Leon ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Conflict of interest; Drug industry; Expert opinion

Indexed keywords

ADVISORY COMMITTEE; DRUG INDUSTRY; EDITORIAL; INFORMATION DISSEMINATION; INFORMATION SEEKING; LEADERSHIP; MEDICAL EXPERT; PATIENT CARE; PHYSICIAN ATTITUDE; PROFESSIONAL DELEGATION; RISK BENEFIT ANALYSIS;

EID: 84864018074     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2012.031     Document Type: Editorial

References (8)

1. Coumou HC, Meijman FJ. How do primary care physicians seek answers to clinical questions? A literature review. J Med Libr Assoc 2006; 94:55-60.
2. McAlister FA, Graham I, Karr GW, Laupacis A. Evidencebased medicine and the practicing clinician. J Gen Intern Med 1999;14: 236-42.
3. Flodgren G, Parmelli E, Doumit G, Gattellari M, O'Brien MA, Grimshaw J, et al. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2011;8:CD000125.
4. Medicines Australia. Code of Conduct. 2010. www.medicinesaustralia.com.au [cited 2012 May 7]
5. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002;324:886-91.
6. Moynihan R. Key opinion leaders: independent experts or drug representatives in disguise? BMJ 2008;336:1402-3.
7. Topol EJ. Failing the public health - Rofecoxib, Merck, and the FDA. N Engl J Med 2004;351:1707-9.
8. The Royal Australasian College of Physicians. Guidelines for ethical relationships between physicians and industry. 3rd ed. 2006. www.racp.edu.au/page/policy-and-advocacy/ethics [cited 2012 May 7]